Analysts say Dogecoin has a 60% chance of hitting $1 before Jan. 31.
Brian Armstrong has reportedly discussed potential policy issues related to cryptocurrencies with US President-elect Donald Trump.
When you think of AI’s contributions to science, you probably think of AlphaFold, the Google DeepMind protein-folding program that earned its creator a Nobel Prize last year.
Now OpenAI says it’s getting into the science game too—with a model for engineering proteins.
The company says it has developed a language model that dreams up proteins capable of turning regular cells into stem cells—and that it has handily beat humans at the task.
The work represents OpenAI’s first model focused on biological data and its first public claim that its models can deliver unexpected scientific results. As such, it is a step toward determining whether or not AI can make true discoveries, which some argue is a major test on the pathway to “artificial general intelligence.”
Last week, OpenAI CEO Sam Altman said he was “confident” his company knows how to build an AGI, adding that “superintelligent tools could massively accelerate scientific discovery and innovation well beyond what we are capable of doing on our own.”
The protein engineering project started a year ago when Retro Biosciences, a longevity research company based in San Francisco, approached OpenAI about working together.
That link-up did not happen by chance. Sam Altman, the CEO of OpenAI, personally funded Retro with $180 million, as MIT Technology Review first reported in 2023.
Retro has the goal of extending the normal human lifespan by 10 years. For that, it studies what are called Yamanaka factors. Those are a set of proteins that, when added to a human skin cell, will cause it to morph into a young-seeming stem cell, a type that can produce any other tissue in the body.
It’s a phenomenon that researchers at Retro, and at richly funded companies like Altos Labs, see as the possible starting point for rejuvenating animals, building human organs, or providing supplies of replacement cells.
But such cell “reprogramming” is not very efficient. It takes several weeks, and less than 1% of cells treated in a lab dish will complete the rejuvenation journey.
OpenAI’s new model, called GPT-4b micro, was trained to suggest ways to re-engineer the protein factors to increase their function. According to OpenAI, researchers used the model’s suggestions to change two of the Yamanaka factors to be more than 50 times as effective—at least according to some preliminary measures.
“Just across the board, the proteins seem better than what the scientists were able to produce by themselves,” says John Hallman, an OpenAI researcher.
Hallman and OpenAI’s Aaron Jaech, as well as Rico Meinl from Retro, were the model’s lead developers.
Outside scientists won’t be able to tell if the results are real until they’re published, something the companies say they are planning. Nor is the model available for wider use—it’s still a bespoke demonstration, not an official product launch.
“This project is meant to show that we’re serious about contributing to science,” says Jaech. “But whether those capabilities will come out to the world as a separate model or whether they’ll be rolled into our mainline reasoning models—that’s still to be determined.”
The model does not work the same way as Google’s AlphaFold, which predicts what shape proteins will take. Since the Yamanaka factors are unusually floppy and unstructured proteins, OpenAI said, they called for a different approach, which its large language models were suited to.
The model was trained on examples of protein sequences from many species, as well as information on which proteins tend to interact with one another. While that’s a lot of data, it’s just a fraction of what OpenAI’s flagship chatbots were trained on, making GPT-4b an example of a “small language model” that works with a focused data set.
Once Retro scientists were given the model, they tried to steer it to suggest possible redesigns of the Yamanaka proteins. The prompting tactic used is similar to the “few-shot” method, in which a user queries a chatbot by providing a series of examples with answers, followed by an example for the bot to respond to.
Although genetic engineers have ways to direct evolution of molecules in the lab, they can usually test only so many possibilities. And even a protein of typical length can be changed in nearly infinite ways (since they’re built from hundreds of amino acids, and each acid comes in 20 possible varieties).
OpenAI’s model, however, often spits out suggestions in which a third of the amino acids in the proteins were changed.
“We threw this model into the lab immediately and we got real-world results,” says Retro’s CEO, Joe Betts-Lacroix. He says the model’s ideas were unusually good, leading to improvements over the original Yamanaka factors in a substantial fraction of cases.
Vadim Gladyshev, a Harvard University aging researcher who consults with Retro, says better ways of making stem cells are needed. “For us, it would be extremely useful. [Skin cells] are easy to reprogram, but other cells are not,” he says. “And to do it in a new species—it’s often extremely different, and you don’t get anything.”
How exactly the GPT-4b arrives at its guesses is still not clear—as is often the case with AI models. “It’s like when AlphaGo crushed the best human at Go, but it took a long time to find out why,” says Betts-Lacroix. “We are still figuring out what it does, and we think the way we apply this is only scratching the surface.”
OpenAI says no money changed hands in the collaboration. But because the work could benefit Retro—whose biggest investor is Altman—the announcement may add to questions swirling around the OpenAI CEO’s side projects.
Last year, the Wall Street Journal said Altman’s wide-ranging investments in private tech startups amount to an “opaque investment empire” that is “creating a mounting list of potential conflicts,” since some of these companies also do business with OpenAI.
In Retro’s case, simply being associated with Altman, OpenAI, and the race toward AGI could boost its profile and increase its ability to hire staff and raise funds. Betts-Lacroix did not answer questions about whether the early-stage company is currently in fundraising mode.
OpenAI says Altman was not directly involved in the work and that it never makes decisions based on Altman’s other investments.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.
We need to protect the protocol that runs Bluesky
—Eli Pariser & Deepti Doshi
Last week, when Mark Zuckerberg announced Meta would be ending third-party fact-checking, it was a shocking pivot, but not exactly surprising. It’s just the latest example of a billionaire flip-flop affecting our social lives on the internet.
Zuckerberg isn’t the only social media CEO careening all over the road: Elon Musk, since buying Twitter in 2022 and touting free speech as “the bedrock of a functioning democracy,” has suspended journalists, restored tens of thousands of banned users, brought back political advertising, and weakened verification and harassment policies.
Unfortunately, these capricious billionaires can do whatever they want because of an ownership model that privileges singular, centralized control in exchange for shareholder returns. The internet doesn’t need to be like this. But as luck would have it, a new way is emerging just in time. Read the full story.
Deciding the fate of “leftover” embryos
Over the past few months, I’ve been working on a piece about IVF embryos. The goal of in vitro fertilization is to create babies via a bit of lab work: Trigger the release of lots of eggs, introduce them to sperm in a lab, transfer one of the resulting embryos into a person’s uterus, and cross your fingers for a healthy pregnancy. Sometimes it doesn’t work. But often it does. For the article, I explored what happens to the healthy embryos that are left over.
These days, responsible IVF clinics will always talk to people about the possibility of having leftover embryos before they begin treatment. But it can be really difficult to make these decisions before you’ve even started treatment, and some people can’t imagine having any left over—or how they might feel about them. Read the full story.
—Jessica Hamzelou
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.
MIT Technology Review Narrated: Palmer Luckey on the Pentagon’s future of mixed reality
Palmer Luckey, the founder of Oculus VR, has set his sights on a new mixed-reality headset customer: the Pentagon. If designed well, his company Anduril’s headset will automatically sort through countless pieces of information and flag the most important ones to soldiers in real time. But that’s a big “if.”
This is our latest story to be turned into a MIT Technology Review Narrated podcast, which we’re publishing each week on Spotify and Apple Podcasts. Just navigate to MIT Technology Review Narrated on either platform, and follow us to get all our new content as it’s released.
The must-reads
I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.
1 The Biden administration won’t force through a TikTok ban
But TikTok could choose to shut itself down on Sunday to prove a point. (ABC News)
+ A Supreme Court decision is expected later today. (NYT $)
+ Every platform has a touch of TikTok about it these days. (The Atlantic $)
2 Apple is pausing its AI news feature
Because it can’t be trusted to meld news stories together without hallucinating. (BBC)
+ The company is working on a fix to roll out in a future software update. (WP $)
3 Meta is preparing for Donald Trump’s mass deportations
By relaxing speech policies around immigration, Meta is poised to shape public opinion towards accepting Trump’s plans to tear families apart. (404 Media)
4 An uncrewed SpaceX rocket exploded during a test flight
Elon Musk says it was probably caused by a leak. (WSJ $)
5 The FBI believes that hackers accessed its agents’ call logs
The data could link investigators to their secret sources. (Bloomberg $)
6 What it’s like fighting fire with water
Dumping water on LA’s wildfires may be inelegant, but it is effective. (NY Mag $)
+ How investigators are attempting to trace the fires’ origins. (BBC)
7 The road to adapting Tesla’s charges for other EVs is far from smooth
But it is happening, slowly but surely. (IEEE Spectrum)
+ Donald Trump isn’t a fan of EVs, but the market is undoubtedly growing. (Vox)
+ Why EV charging needs more than Tesla. (MIT Technology Review)
8 Bionic hands are getting far more sensitive
A new study is shedding light on how to make them feel more realistic. (FT $)
+ These prosthetics break the mold with third thumbs, spikes, and superhero skins. (MIT Technology Review)
9 Gen Z can’t get enough of astrology apps
Stargazing is firmly back ein vogue among the younger generations. (Economist $)
10 Nintendo has finally unveiled its long-awaited Switch 2 console
Only for it to look a whole lot like its predecessor. (WSJ $)
+ But it’ll probably sell a shedload of units anyway. (Wired $)
Quote of the day
“Going viral is like winning the lottery—nearly impossible to replicate.”
—Sarah Schauer, a former star on defunct video app Vine, offers creators left nervous by TikTok’s uncertain future in the US some advice, the Washington Post reports.
The big story
After 25 years of hype, embryonic stem cells are still waiting for their moment
August 2023
In 1998, researchers isolated powerful stem cells from human embryos. It was a breakthrough, since these cells are the starting point for human bodies and have the capacity to turn into any other type of cell—heart cells, neurons, you name it.
National Geographic would later summarize the incredible promise: “the dream is to launch a medical revolution in which ailing organs and tissues might be repaired” with living replacements. It was the dawn of a new era. A holy grail. Pick your favorite cliché—they all got airtime.
Yet today, more than two decades later, there are no treatments on the market based on these cells. Not one. Our biotech editor Antonio Regalado set out to investigate why, and when that might change. Here’s what he discovered.
We can still have nice things
A place for comfort, fun and distraction to brighten up your day. (Got any ideas? Drop me a line or skeet ’em at me.)
+ If you’re planning on catching up with a friend this weekend—stop! You should be hanging out instead.
+ David Lynch was a true visionary; an innovative artist and master of the truly weird. The world is a duller place without him.
+ The very best instant noodles, ranked ($)
+ Congratulations to the highly exclusive Cambridge University Tiddlywinks Club, which is celebrating its 70th anniversary.
Last week, when Mark Zuckerberg announced that Meta would be ending third-party fact-checking, it was a shocking pivot, but not exactly surprising. It’s just the latest example of a billionaire flip-flop affecting our social lives on the internet.
After January 6, 2021, Zuckerberg bragged to Congress about Facebook’s “industry-leading fact-checking program” and banned Donald Trump from the platform. But just two years later, he welcomed Trump back. And last year Zuckerberg was privately reassuring the conservative congressman Jim Jordan that Meta will no longer demote questionable content while it’s being fact-checked.
Now, not only is Meta ending fact-checking completely; it is loosening rules around hate speech, allowing horrendous personal attacks on migrants and trans people, for example, on its platforms.
And Zuckerberg isn’t the only social media CEO careening all over the road: Elon Musk, since buying Twitter in 2022 and touting free speech as “the bedrock of a functioning democracy,” has suspended journalists, restored tens of thousands of banned users (including white nationalists), brought back political advertising, and weakened verification and harassment policies.
Unfortunately, these capricious billionaires can do whatever they want because of an ownership model that privileges singular, centralized control in exchange for shareholder returns.
And this has led to a constantly shifting digital environment in which people can lose their communication pathways and livelihoods in a second, with no recourse, as opaque rules change.
The internet doesn’t need to be like this. As luck would have it, a new way is emerging just in time.
If you’ve heard of Bluesky, you’ve probably heard of it as a clone of Twitter where liberals can take refuge. But under the hood it’s structured fundamentally differently—in a way that could point us to a healthier internet for everyone, regardless of politics or identity.
Just like email, Bluesky sits on top of an open protocol, in this case known as the AT Protocol. In practice, that means that anyone can build on it. Just as you wouldn’t need anyone’s permission to start a newsletter company built on email, people are starting to share remixed versions of their social media feeds, built on Bluesky. This sounds like a small thing, but think about all the harms enabled by social media companies’ algorithms in the last decade: insurrection, radicalization, self-harm, bullying. Bluesky enables users to collaborate on verification and moderation by sharing block lists and labels. Letting people shape their own experience of social media is nothing short of revolutionary.
And importantly, if you decide that you don’t agree with Bluesky’s design and moderation decisions, you can build something else on the same infrastructure and use that instead. This is fundamentally different from the dominant, centralized social media that has prevailed until now.
At the core of Bluesky’s philosophy is the idea that instead of being centralized in the hands of one person or institution, social media governance should obey the principle of subsidiarity. The Nobel Prize–winning economist Elinor Ostrom found, through studying grassroots solutions to local environmental problems around the world, that some problems are best solved locally, while others are best solved at a higher level.
In terms of content moderation, posts related to child sexual abuse or terrorism are best handled by professionals trained to help keep millions or billions safe. But a lot of decisions about speech can be solved in each community, or even user by user as people assemble Bluesky block lists.
So all the right elements are currently in place at Bluesky to usher in this new architecture for social media: independent ownership, newfound popularity, a stark contrast with other dominant platforms, and right-minded leadership. But challenges remain, and we can’t count on Bluesky to do this right without support.
Critics have pointed out that Bluesky has yet to turn a profit and is currently running on venture capital, the same corporate structure that brought us Facebook, Twitter, and other social media companies. As of now, there’s no option to exit Bluesky and take your data and network with you, because there are no other servers that run the AT Protocol. Bluesky CEO Jay Graber deserves credit for her stewardship so far, and for attempting to avoid the dangers of advertising incentives. But the process by which capitalism degrades tech products is so predictable that Cory Doctorow coined a now-popular term for it: enshittification.
That’s why we need to act now to secure the foundation of this digital future and make it enshittification-proof. This week, prominent technologists started a new project, which we at New_ Public are supporting, called Free Our Feeds. There are three parts: First, Free Our Feeds wants to create a nonprofit foundation to govern and protect the AT Protocol, outside of Bluesky the company. We also need to build redundant servers so all users can leave with their data or build anything they want—regardless of policies set by Bluesky. Finally, we need to spur the development of a whole ecosystem built on this tech with seed money and expertise.
It’s worth noting that this is not a hostile takeover: Bluesky and Graber recognize the importance of this effort and have signaled their approval. But the point is, it can’t rely on them. To free us from fickle billionaires, some of the power has to reside outside Bluesky, Inc.
If we get this right, so much is possible. Not too long ago, the internet was full of builders and people working together: the open web. Email. Podcasts. Wikipedia is one of the best examples—a collaborative project to create one of the web’s best free, public resources. And the reason we still have it today is the infrastructure built up around it: The nonprofit Wikimedia Foundation protects the project and insulates it from the pressures of capitalism. When’s the last time we collectively built anything as good?
We can shift the balance of power and reclaim our social lives from these companies and their billionaires. This is an opportunity to bring much more independence, innovation, and local control to our online conversations. We can finally build the “Wikipedia of social media,” or whatever we want. But we need to act, because the future of the internet can’t depend on whether one of the richest men on Earth wakes up on the wrong side of the bed.
Eli Pariser is author of The Filter Bubble and Co-Director of New_ Public, a nonprofit R&D lab that’s working to reimagine social media.
Deepti Doshi is a Co-Director of New_ Public and was a director at Meta.
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.
Over the past few months, I’ve been working on a piece about IVF embryos. The goal of in vitro fertilization is to create babies via a bit of lab work: Trigger the release of lots of eggs, introduce them to sperm in a lab, transfer one of the resulting embryos into a person’s uterus, and cross your fingers for a healthy pregnancy. Sometimes it doesn’t work. But often it does. For the article, I explored what happens to the healthy embryos that are left over.
I spoke to Lisa Holligan, who had IVF in the UK around five years ago. Holligan donated her “genetically abnormal” embryos for scientific research. But she still has one healthy embryo frozen in storage. And she doesn’t know what to do with it.
She’s not the only one struggling with the decision. “Leftover” embryos are kept frozen in storage tanks, where they sit in little straws, invisible to the naked eye, their growth paused in a state of suspended animation. What happens next is down to personal choice—but that choice can be limited by a complex web of laws and ethical and social factors.
These days, responsible IVF clinics will always talk to people about the possibility of having leftover embryos before they begin treatment. Intended parents will sign a form indicating what they would like to happen to those embryos. Typically, that means deciding early on whether they might like any embryos they don’t end up using to be destroyed or donated, either to someone else trying to conceive or for research.
But it can be really difficult to make these decisions before you’ve even started treatment. People seeking fertility treatment will usually have spent a long time trying to get pregnant. They are hoping for healthy embryos, and some can’t imagine having any left over—or how they might feel about them.
For a lot of people, embryos are not just balls of cells. They hold the potential for life, after all. Some people see them as children, waiting to be born. Some even name their embryos, or call them their “freezer babies.” Others see them as the product of a long, exhausting, and expensive IVF journey.
Holligan says that she initially considered donating her embryo to another person, but her husband disagreed. He saw the embryo as their child and said he wouldn’t feel comfortable with giving it up to another family. “I started having these thoughts about a child coming to me when they’re older, saying they’ve had a terrible life, and [asking] ‘Why didn’t you have me?’” she told me.
Holligan lives in the UK, where you can store your embryos for up to 55 years. Destroying or donating them are also options. That’s not the case in other countries. In Italy, for example, embryos cannot be destroyed or donated. Any that are frozen will remain that way forever, unless the law changes at some point.
In the US, regulations vary by state. The patchwork of laws means that one state can bestow a legal status on embryos, giving them the same rights as children, while another might have no legislation in place at all.
No one knows for sure how many embryos are frozen in storage tanks, but the figure is thought to be somewhere between 1 million and 10 million in the US alone. Some of these embryos have been in storage for years or decades. In some cases, the intended parents have deliberately chosen this, opting to pay hundreds of dollars per year in fees.
But in other cases, clinics have lost touch with their clients. Many of these former clients have stopped paying for the storage of their embryos, but without up-to-date consent forms, clinics can be reluctant to destroy them. What if the person comes back and wants to use those embryos after all?
“Most clinics, if they have any hesitation or doubt or question, will err on the side of holding on to those embryos and not discarding them,” says Sigal Klipstein, a reproductive endocrinologist at InVia Fertility Center in Chicago, who also chairs the ethics committee of the American Society for Reproductive Medicine. “Because it’s kind of like a one-way ticket.”
Klipstein thinks one of the reasons why some embryos end up “abandoned” in storage is that the people who created them can’t bring themselves to destroy them. “It’s just very emotionally difficult for someone who has wanted so much to have a family,” she tells me.
Klipstein says she regularly talks to her patients about what to do with leftover embryos. Even people who make the decision with confidence can change their minds, she says. “We’ve all had those patients who have discarded embryos and then come back six months or a year later and said: ‘Oh, I wish I had those embryos,’” she tells me. “Those [embryos may have been] their best chance of pregnancy.”
Those who do want to discard their embryos have options. Often, the embryos will simply be exposed to air and then disposed of. But some clinics will also offer to transfer them at a time or place where a pregnancy is extremely unlikely to result. This “compassionate transfer,” as it is known, might be viewed as a more “natural” way to dispose of the embryo.
But it’s not for everyone. Holligan has experienced multiple miscarriages and wonders if a compassionate transfer might feel similar. She wonders if it might just end up “putting [her] body and mind through unnecessary stress.”
Ultimately, for Holligan and many others in a similar position, the choice remains a difficult one. “These are … very desired embryos,” says Klipstein. “The purpose of going through IVF was to create embryos to make babies. And [when people] have these embryos, and they’ve completed their family plan, they’re in a place they couldn’t have imagined.”
Now read the rest of The Checkup
Read more from MIT Technology Review‘s archive
Our relationship with embryos is unique, and a bit all over the place. That’s partly because we can’t agree on their moral status. Are they more akin to people or property, or something in between? Who should get to decide their fate? While we get to the bottom of these sticky questions, millions of embryos are stuck in suspended animation—some of them indefinitely.
It is estimated that over 12 million babies have been born through IVF. The development of the Nobel Prize–winning technology behind the procedure relied on embryo research. Some worry that donating embryos for research can be onerous—and that valuable embryos are being wasted as a result.
Fertility rates around the world are dropping below the levels needed to maintain stable populations. But IVF can’t save us from a looming fertility crisis. Gender equality and family-friendly policies are much more likely to prove helpful.
Two years ago, the US Supreme Court overturned Roe v. Wade, a legal decision that protected the right to abortion. Since then, abortion bans have been enacted in multiple states. But in November of last year, some states voted to extend and protect access to abortion, and voters in Missouri supported overturning the state’s ban.
Last year, a ruling by the Alabama Supreme Court that embryos count as children ignited fears over access to fertility treatments in a state that had already banned abortion. The move could also have implications for the development of technologies like artificial uteruses and synthetic embryos, my colleague Antonio Regalado wrote at the time.
From around the web
It’s not just embryos that are frozen as part of fertility treatments. Eggs, sperm, and even ovarian and testicular tissue can be stored too. A man who had immature testicular tissue removed and frozen before undergoing chemotherapy as a child 16 years ago had the tissue reimplanted in a world first, according to the team at University Hospital Brussels that performed the procedure around a month ago. The tissue was placed into the man’s testicle and scrotum, and scientists will wait a year before testing to see if he is successfully producing sperm. (UZ Brussel)
The Danish pharmaceutical company Novo Nordisk makes half the world’s insulin. Now it is better known as the manufacturer of the semaglutide drug Ozempic. How will the sudden shift affect the production and distribution of these medicines around the world? (Wired)
The US has not done enough to prevent the spread of the H5N1 virus in dairy cattle. The response to bird flu is a national embarrassment, argues Katherine J. Wu. (The Atlantic)
Elon Musk has said that if all goes well, millions of people will have brain-computer devices created by his company Neuralink implanted within 10 years. In reality, progress is slower—so far, Musk has said that three people have received the devices. My colleague Antonio Regalado predicts what we can expect from Neuralink in 2025. (MIT Technology Review)
Seems a like a high-risk low-reward approach, but…
The Supreme Court has upheld the approved bill that will force TikTok out of the US.
A Bitcoin price of $150,000 may be “absolutely silly low,” says a crypto trader, citing the expected widespread adoption by countries and corporations that will use it as a store of value.
The executive order would instruct regulatory agencies to work with the industry and create a crypto council to represent the industry, according to people familiar with the plans.